Events

Executive dysfunction and emotional dysregulation are common major contributors to ADHD impairment, yet these features are often overlooked during clinical assessments 1-3. Dr. Childress will discuss how to understand and recognize features of executive dysfunction and emotional dysregulation in individuals with attention-deficit/hyperactivity disorder (ADHD). She will review the approaches for assessing executive dysfunction and emotional dysregulation and discuss the limitations of current pharmacological therapies for executive dysfunction and emotional dysregulation.

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.